72 related articles for article (PubMed ID: 28784723)
21. [Mechanisms and clinical uses of miRNAs in colorectal cancer].
Ogawa Y; Mimori K
Nihon Rinsho; 2016 Nov; 74(11):1807-1811. PubMed ID: 30550686
[TBL] [Abstract][Full Text] [Related]
22. microRNA-Mediated Tumor-Microbiota Metabolic Interactions in Colorectal Cancer.
Yuan C; Subramanian S
DNA Cell Biol; 2019 Apr; 38(4):281-285. PubMed ID: 30668143
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B.
Li Y; Chen M; Liu J; Li L; Yang X; Zhao J; Wu M; Ye M
Mol Cell Biol; 2017 Nov; 37(22):. PubMed ID: 28784723
[TBL] [Abstract][Full Text] [Related]
24. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
[TBL] [Abstract][Full Text] [Related]
25. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
Wu W; Wang Z; Yang P; Yang J; Liang J; Chen Y; Wang H; Wei G; Ye S; Zhou Y
Mol Cell Biochem; 2014 Mar; 388(1-2):249-59. PubMed ID: 24343340
[TBL] [Abstract][Full Text] [Related]
29. MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways.
Wu JH; Wang YH; Wang W; Shen W; Sang YZ; Liu L; Chen CM
Int J Biochem Cell Biol; 2016 Apr; 73():41-52. PubMed ID: 26851511
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis.
Yin Y; Song M; Gu B; Qi X; Hu Y; Feng Y; Liu H; Zhou L; Bian Z; Zhang J; Zuo X; Huang Z
Gene; 2016 Mar; 578(2):177-84. PubMed ID: 26692142
[TBL] [Abstract][Full Text] [Related]
31. Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer.
Azizian A; Kramer F; Jo P; Wolff HA; Beißbarth T; Skarupke R; Bernhardt M; Grade M; Ghadimi BM; Gaedcke J
World J Surg; 2015 Sep; 39(9):2329-35. PubMed ID: 25990502
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
Qu LL; He L; Zhao X; Xu W
Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
[TBL] [Abstract][Full Text] [Related]
33. Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery.
Basu RK; Wong HR; Krawczeski CD; Wheeler DS; Manning PB; Chawla LS; Devarajan P; Goldstein SL
J Am Coll Cardiol; 2014 Dec; 64(25):2753-62. PubMed ID: 25541128
[TBL] [Abstract][Full Text] [Related]
34. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma.
Li J; Bi L; Lin Y; Lu Z; Hou G
Drug Des Devel Ther; 2014; 8():2129-36. PubMed ID: 25382971
[TBL] [Abstract][Full Text] [Related]
36. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next?
Okugawa Y; Toiyama Y; Goel A
Expert Rev Mol Diagn; 2014 Nov; 14(8):999-1021. PubMed ID: 25163355
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
